A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023
Open Access
- 11 November 2025
- journal article
- review article
- Published by Springer Nature in Communications Medicine
- Vol. 5 (1) , 468
Abstract
This review summarizes key virological parameters of SARS-CoV-2, the clinical spectrum of COVID-19, antiviral options, resistance, and the evolution of SARS-CoV-2 during the first four years of the pandemic. It draws on evidence that has been continuously updated throughout the pandemic by the interdisciplinary working group ‘SARS-CoV-2 Diagnostics and Evolution’ at Robert Koch Institute (RKI), Germany’s national public health institute. We describe basic SARS-CoV-2 characteristics and highlight notable virus variants from 2020 to mid-2023. During this period, the nationwide collection of SARS-CoV-2 genomes provided a substantial resource for monitoring viral lineage frequencies and mutations. We summarize this dataset to underscore the importance of virological surveillance in the context of public health and pandemic preparedness.Keywords
Funding Information
- Bundesministerium für Gesundheit (D82015, sub-projects C1.1 and C.1.2)
- European Centre for Disease Prevention and Control (ECDC/HERA/2021/008 ECD.12222)
- European Centre for Disease Prevention and Control (101113012)
This publication has 309 references indexed in Scilit:
- Association of Treatment With Nirmatrelvir and the Risk of Post–COVID-19 ConditionJAMA Internal Medicine, 2023
- Clinical characteristics of 1139 mild cases of the SARS‐CoV‐2 Omicron variant infected patients in ShanghaiJournal of Medical Virology, 2022
- SARS‐CoV‐2 cellular tropism and direct multiorgan failure in COVID‐19 patients: Bioinformatic predictions, experimental observations, and open questionsCell Biology International, 2022
- Proportion of asymptomatic infection and nonsevere disease caused by SARS‐CoV‐2 Omicron variant: A systematic review and analysisJournal of Medical Virology, 2022
- Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 StrainsJAMA Network Open, 2022
- Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in IsraelJAMA, 2022
- Genetic Variants of SARS-CoV-2—What Do They Mean?JAMA, 2021
- Smell and taste symptom‐based predictive model for COVID‐19 diagnosisInternational Forum of Allergy & Rhinology, 2020
- Myocardial Localization of Coronavirus in COVID-19 Cardiogenic ShockEuropean Journal of Heart Failure, 2020
- Data, disease and diplomacy: GISAID's innovative contribution to global healthGlobal Challenges, 2017